Brenda S. Furlow sold $677k of TECH
SVP - GENERAL COUNSEL at BIO-TECHNE Corp. 8,250 shares at an average of $82.11, traded Dec 7, 2022, filed Dec 9, 2022.
Score components
- +15RoleOfficer
- +20Trade size$677k at market
- +10Share of holdings soldSold 31% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001415889-22-012330, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 7, 2022 | MOption exercise Common Stock | +800 | $31.26 | $25k | 26,892 | Dec 9, 2022 |
| Dec 7, 2022 | SOpen-market sale Common Stock | -800 | $82.01 | $66k | 26,092 | Dec 9, 2022 |
| Dec 8, 2022 | MOption exercise Common Stock | +7,450 | $31.26 | $233k | 33,542 | Dec 9, 2022 |
| Dec 8, 2022 | SOpen-market sale Common Stock | -7,450 | $82.12 | $612k | 26,092 | Dec 9, 2022 |
| Dec 7, 2022 | MOption exercise Stock Options (Right to Buy)derivative | -800 | $0.00 | $0 | 37,212 | Dec 9, 2022 |
| Dec 8, 2022 | MOption exercise Stock Options (Right to Buy)derivative | -7,450 | $0.00 | $0 | 29,762 | Dec 9, 2022 |
Related signals
Other insiders at BIO-TECHNE Corp and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 34Weak | TECHsell BIO-TECHNE Corp | Amy E. Herr director | $320k 6,636 shares | -97% | |
| 45Moderate | TECHsell BIO-TECHNE Corp | Amy E. Herr director | $117k 1,976 shares | -91% | |
| 42Moderate | BIO-TECHNE Corp | Robert Baumgartner V director | $958k 17,040 shares | -28% | |
| 42Moderate | BIO-TECHNE Corp | Roeland Nusse director | $960k 17,040 shares | -28% | |
| 18Weak | TECHsell BIO-TECHNE Corp | Amy E. Herr director | $64k 1,280 shares | -39% | |
| 20Weak | TECHsell BIO-TECHNE Corp | Amy E. Herr director | $123k 1,860 shares | -48% | |
| 45Moderate | TECHsell BIO-TECHNE Corp | Kim Kelderman Chief Executive Officer | $1.0M 13,392 shares | -26% | |
| 35Weak | TECHsell BIO-TECHNE Corp | Robert Baumgartner V director | $1.2M 16,000 shares | -27% | |
| 15Weak | TECHsell BIO-TECHNE Corp | John L Higgins director | $335k 4,000 shares | -10% | |
| 42Moderate | TECHsell BIO-TECHNE Corp | Roeland Nusse director | $801k 10,400 shares | -19% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.